Chemours annual ebitda margin
2013
2014
2015
2022
2023
2024
2025
Chemours EBITDA Margin Growth & History (CC)
Chemours's ebitda margin was 5.72% for fiscal 2025.
View full Chemours company overviewChemours annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 5.72% | −5.72 pp |
| 2024 | 2024-12-31 | 11.43% | +8.16 pp |
| 2023 | 2023-12-31 | 3.27% | −14.22 pp |
| 2022 | 2022-12-31 | 17.49% | — |
| 2015 | 2015-12-31 | 85.66% | −5.14 pp |
| 2014 | 2014-12-31 | 90.80% | +0.61 pp |
| 2013 | 2013-12-31 | 90.19% | — |
Chemours quarterly ebitda margin
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 9.24% | +14.75 pp |
| Q1 2026 | 2026-03-31 | 9.12% | — |
| Q4 2025 | 2025-12-31 | 6.17% | — |
| Q3 2025 | 2025-09-30 | 13.24% | — |
| Q2 2025 | 2025-06-30 | −5.51% | — |
| Q3 2016 | 2016-09-30 | 88.98% | +10.11 pp |
| Q2 2016 | 2016-06-30 | 86.62% | −1.57 pp |
| Q1 2016 | 2016-03-31 | 91.75% | +0.99 pp |
| Q4 2015 | 2015-12-31 | 85.15% | — |
| Q3 2015 | 2015-09-30 | 78.87% | −11.82 pp |
| Q2 2015 | 2015-06-30 | 88.20% | −1.17 pp |
| Q1 2015 | 2015-03-31 | 90.76% | — |
| Q3 2014 | 2014-09-30 | 90.69% | — |
| Q2 2014 | 2014-06-30 | 89.37% | — |
Chemours ebitda margin trends
Between the periods ended 2013-12-31 and 2025-12-31, Chemours's ebitda margin decreased from 90.19% to 5.72%, a change of −84.47 percentage points. The latest reported quarter, Q2 2026, shows 9.24%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...